Labcorp Holdings Inc.

NYSE:LH

Medical - Diagnostics & Research

Healthcare
$370.78 -1.33%

-$3.46 today

Market cap
$30.11B
Beta
0.88
P/E (TTM)
22.4
EPS (TTM)
$11.44
Dividend yield
1.12%
52W Low $241.81High $293.72

Volume 0.69M

Average 0.63M

LH Interest Expense

Cost of servicing the company's debt during the period.

Labcorp Holdings Inc.NYSE: LH

Interest Expense · Q2 FY2026 · quarter ended Jun 2026

Interest expense growth accelerates

Q2 FY2026 interest expense of $61.1M rose 7.0% year over year, ahead of the +0.1% change in trailing-twelve-month interest expense. Sequentially, it rose 10.9% from the prior quarter. Over 3 fiscal years it compounded at +7.6% a year.

Context

  • Interest expense amounted to 1.6% of revenue in FY2025, unchanged from a year earlier.
  • Interest expense increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +7.0% holds above the trailing-twelve-month pace of +0.1%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$61.1M+10.9% QoQ
Last fiscal yearDec 2025
$224.1M+7.6% YoY
LTMJun 2026
$227.2M+0.1% YoY
Interest Expense past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+7.0%——
1 year+7.6%——
3-year CAGR+7.6%——
5-year CAGR——
10-year CAGR——

Interest Expense history

USD · from the income statement

Latest · FY2025
224.1M USD
Year-over-year change
+7.6%
4-year CAGR
+1.4%

Interest Expense vs competitors

How LH compares with its peers on the latest reported figures

  • LH's LTM Jun 2026 interest expense of $227.2M is the 3rd highest of the 7 companies compared; the peer median is $24.7M.
  • Its year-over-year change of +0.1% is the 5th highest of 6, against a peer median of +6.9%.
  • Interest expense amounts to 1.6% of revenue for LH, versus a peer median of 1.1%.
LH Competitors Peer median
Interest Expense for LH and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TMOThermo Fisher Scientific Inc.LTM Sep 2026$1.54B +6.9%+25.0%3.2%
DGXQuest Diagnostics IncorporatedLTM Sep 2026$254M -9.9%+23.2%2.1%
LHLabcorp Holdings Inc.LTM Jun 2026$227.2M +0.1%+7.6%1.6%
QGENQiagen N.V.LTM Jun 2026$39.43M +5.1%-17.1%1.9%
NTRANatera, Inc.LTM Jun 2026$9.97M +54.2%-24.1%0.4%
GHGuardant Health, Inc.LTM Sep 2026$5.22M +55.2%+14.8%0.4%
GRALGRAIL, Inc.LTM Jun 2026$0 ——0.0%
Peer median (excluding LH) $24.7M+6.9%+14.8%1.1%

Competitors are the stored peer set for LH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue13.14B11.86B12.16B13.01B13.95B
Cost of Revenue8.14B8.16B8.8B9.38B10.22B
Gross Profit4.99B3.71B3.36B3.62B3.73B
Gross Margin38.0%31.3%27.7%27.9%26.8%
Research & Development002M00
Selling, General & Admin1.69B2B2.02B2.23B2.22B
Operating Expenses1.94B2.27B2.64B2.54B2.22B
Depreciation & Amortization577M537.2M577.3M643.5M681.1M
EBITDA3.68B1.95B1.35B1.81B2.01B
EBITDA Margin28.0%16.5%11.1%13.9%14.4%
Operating Income3.05B1.44B725.6M1.09B1.52B
Operating Margin23.2%12.1%6.0%8.4%10.9%
Interest Income000015.2M
Interest Expense211.8M179.8M199.6M208.3M224.1M
Other Income / Expenses(161M)(199.1M)(156.7M)(127.2M)(408.7M)
Income Before Tax2.89B1.24B568.9M959.5M1.11B
Pre-Tax Margin22.0%10.4%4.7%7.4%7.9%
Income Tax Expense690M233.9M188.5M212.4M229.8M
Net Income2.38B1.28B418M746M876.5M
Net Margin18.1%10.8%3.4%5.7%6.3%
EPS (Basic)24.5814.044.808.8910.54
EPS (Diluted)24.3813.964.778.8410.46
Weighted Avg Shares96.7M91.1M87.1M83.9M83.2M
Weighted Avg Shares (Diluted)97.5M91.6M87.6M84.4M83.8M

Labcorp Holdings Inc.

NYSE:LH

Intrinsic Alpha fair value

Locked

Current Price

$370.78

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.